Skip to main content

How much should you exercise for a longer, healthier life?

The amount of exercise needed for a longer, healthier life can vary based on individual factors such as age, health status, and personal fitness goals. However, general guidelines provided by health organizations can offer a starting point. The World Health Organization (WHO) and many health experts recommend the following: Aerobic Exercise: Adults should aim for at least 150 minutes of moderate-intensity aerobic exercise or 75 minutes of vigorous-intensity aerobic exercise per week. Alternatively, a combination of moderate and vigorous activity can be done. Strength Training: In addition to aerobic exercise, adults should engage in muscle-strengthening activities on 2 or more days a week. This can include weight lifting, bodyweight exercises, or other forms of resistance training. Balance and Flexibility: Include balance and flexibility exercises to enhance overall physical fitness. These activities can reduce the risk of falls and injuries, especially in older adults. It's important to note that these are general recommendations, and individual needs may vary. Some people may need more or less exercise based on their health condition, fitness level, and personal goals. It's also beneficial to incorporate regular physical activity into your daily routine, such as walking, taking the stairs, or participating in recreational activities. The key is to find activities you enjoy, as this increases the likelihood that you'll stick with them over the long term. Before starting a new exercise program, especially if you have any existing health concerns, it's advisable to consult with a healthcare professional or fitness expert to ensure that the chosen activities are safe and suitable for your individual circumstances. Regular exercise, combined with a balanced diet and other healthy lifestyle choices, can contribute to a longer and healthier life.

Comments

Popular posts from this blog

Ignoring influenza and flu in winter can be Dangerous

Ignoring influenza (the flu) and flu-like symptoms during the winter can indeed be dangerous. Influenza is a viral infection that primarily spreads through respiratory droplets when an infected person coughs or sneezes. It tends to be more prevalent during the colder months, which is why it's often associated with winter. Here are some reasons why ignoring the flu in winter can be dangerous: Complications: The flu can lead to serious complications, especially in vulnerable populations such as young children, the elderly, pregnant women, and individuals with weakened immune systems. Complications can include pneumonia, bronchitis, sinus infections, and ear infections. Spread of the Virus: Influenza is highly contagious, and neglecting symptoms can contribute to the spread of the virus to others. This is particularly concerning in crowded places like schools, offices, and public transportation. Weakened Immune System: The winter season itself can weaken the immune system, making ...

What Is a Secondary Headache?

A secondary headache is a type of headache that is a symptom of another underlying medical condition or disease. Unlike primary headaches, which are not associated with any underlying cause, secondary headaches are a result of an identifiable and usually serious underlying problem. There are numerous potential causes of secondary headaches, including: Head Injury: Traumatic head injuries can lead to headaches as a symptom. Sinusitis: Inflammation of the sinuses can cause pain and pressure in the head. Migraines: While migraines can be primary headaches, they can also be secondary if they are triggered by an underlying condition. Medication Overuse: Excessive use of pain medications, especially those containing caffeine or codeine, can lead to rebound headaches. Infection: Various infections, such as meningitis, encephalitis, or a sinus infection, can cause secondary headaches. High Blood Pressure: Hypertension (high blood pressure) can lead to headaches, especially if it is seve...

FDA Approves Pfizer’s Vaccine for Meningococcal Disease

The U.S. Food and Drug Administration has approved Pfizer’s application for Penbraya, a vaccine for people 10 through 25 that will offer protection against the five main kinds of bacteria that cause meningitis and blood poisoning. The new drug will reduce the number of doses that people need to be fully vaccinated, Pfizer said in a news release. Penbraya will be given as a two-dose series administered six months apart, Pfizer said. Medical authorities currently recommend Trumenba for meningococcal group B and Nimenrix for meningococcal groups A, C, W-135, and Y, meaning people need four doses for full protection. “In a single vaccine, PENBRAYA has the potential to protect more adolescents and young adults from this severe and unpredictable disease by providing the broadest meningococcal coverage in the fewest shots,” Annaliesa Anderson, PhD, senior vice president and head of vaccine research and development for Pfizer, said in the release. Penbraya combines Trumenba, which is mad...